Tesamorelin 10mg

$70.00

Purity:99.673%

Quantity: 11.62mg

Note: This Certificate of Analysis (COA) provided for this compound reflects third-party laboratory testing from the original manufacturing batch. This report is shared for transparency and reference purposes only. The COA was not issued directly to Moxie Pure Research.

14 in stock

Category: Tag:

Description

Tesamorelin is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed to stimulate the pituitary gland to increase growth hormone (GH) secretion. It is commonly studied for its effects on fat metabolism, body composition, and tissue repair in research settings.

How It Works

  • Binds to GHRH receptors in the pituitary, prompting the release of growth hormone.

  • Stimulates pulsatile GH release, supporting natural regulatory patterns.

  • Often used in combination with GHRPs such as Ipamorelin or CJC-1295 (No DAC) to amplify GH secretion and enhance regenerative outcomes.


Potential Research Benefits

  • Fat Reduction & Body Composition – GH stimulation promotes lipolysis and may help reduce visceral and abdominal fat in research models.

  • Muscle & Tissue Repair – Supports lean muscle maintenance, protein synthesis, and connective tissue regeneration.

  • Bone Health & Connective Tissue Support – GH pathways contribute to increased bone density and tendon/ligament strength.

  • Anti-Aging & Recovery Support – May support skin elasticity, energy metabolism, and overall tissue regeneration.

  • Controlled GH Stimulation – Shorter-acting profile allows for study of specific GH release patterns without prolonged systemic exposure.


Combination Use Note

Tesamorelin is frequently combined with GHRPs such as Ipamorelin or CJC-1295 (No DAC) in research protocols to maximize growth hormone release and enhance tissue repair and regenerative outcomes.


Disclaimer & Safety Notes

  • For research use only

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin 10mg”

Your email address will not be published. Required fields are marked *